Contineum Therapeutics (CTNM) Revenue (2023)
Contineum Therapeutics (CTNM) recorded quarterly Revenue of $50.0 million in Q2 2023.
Contineum Therapeutics (CTNM) Revenue (2023) Analysis & Trends
Contineum Therapeutics' Revenue history runs 1 years deep, the most recent figure standing at $50.0 million for Q2 2023.
- In Q2 2023, Revenue changed N/A year-over-year to $50.0 million; the TTM figure through Jun 2024 stood at $50.0 million (changed N/A YoY), while the FY2023 annual figure was $50.0 million, changed N/A from the prior year.
- Revenue was $50.0 million for Q2 2023 at Contineum Therapeutics.
- In the past five years, Revenue ranged from a high of $50.0 million in Q2 2023 to a low of $50.0 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Contineum Therapeutics | 430.52 Mn | 430.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 50.00 Mn |